Basic Research

HOME > R&D Achievement > Basic Research > Article
 
DATE : 21-06-10 11:53
Novel porcine model of acute myocardial infarction using polyethylene terephthalate
 WRITER : stent
HIT : 1,371  
   B98.+Novel+porcine+model+of+acute+myocardial+infarction+using+polyethylene+terephthalate+_1_.pdf (4.3M) [0] DATE : 2021-06-10 11:53:51
Yong Sook Kim, Nan Yeol Kim, In-Ho Bae, Jun Kyu Park, Dae Sung Park, Jae Won Shim, Wan Suk Kang, Han Byul Kim, Bong-Seok Song, Bon-Sang Koo, Kang-Jin Jeong, Sun-Uk Kim, Hyun Kuk Kim, Sung Soo Kim, Min Chul Kim

Novel porcine model of acute myocardial infarction using polyethylene terephthalate

Journal of Biomedical and Translational Research

Acute myocardial infarction (AMI) is considered the major cause of mortality in the world. Tremendous animal studies are performed to develop novel therapeutics, and this study aimed to induce porcine myocardial infarction model by using polyethylene terephthalate (PET). Coronary guidewire was placed in left anterior descending artery (LAD). The balloon angioplasty catheter was inserted at the back of the PET. The balloon catheter was carefully pushed forward, until the balloon marker was located in mid-LAD. Coronary angiography was performed pre- and post-occlusion at 28 days by C-arm. Histologic analysis of heart tissue was performed 28 days after inducing AMI. Thirty three pigs were anesthetized and underwent percutaneous coronary catheterization. All pigs were successfull embolized in mid-LAD by PET. Fifteen pigs died due to ventricular fibrillation during post-anesthetic recovery time, and overall experiment mortality was 45.5%. In 2,3,5-triphenyl tetrazolium chloride staining, gross finding of the ischemic heart lesion showed firm and white area of infarction associated with the apex and left ventricular posterior wall. Infarct on H&E-stained sections demon- strated a region without myocytes and rich with cardio- myocyte with atypical nuclei. Successful induction of  AMI by using PET may provide the pathophysiological  information of ischemic heart disease and improvement  of therapy development for AMI.